New York State Common Retirement Fund Increases Stake in AdaptHealth Corp. (NASDAQ:AHCO)

New York State Common Retirement Fund lifted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 10.3% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 836,773 shares of the company's stock after purchasing an additional 78,211 shares during the quarter. New York State Common Retirement Fund owned about 0.62% of AdaptHealth worth $9,071,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in AHCO. GAMMA Investing LLC boosted its holdings in AdaptHealth by 175.2% in the first quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after purchasing an additional 4,758 shares during the period. Guggenheim Capital LLC increased its stake in AdaptHealth by 10.1% in the 4th quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after purchasing an additional 1,525 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in AdaptHealth in the 4th quarter worth approximately $169,000. Humankind Investments LLC raised its stake in shares of AdaptHealth by 18.3% during the 4th quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock worth $171,000 after purchasing an additional 2,776 shares in the last quarter. Finally, Proficio Capital Partners LLC bought a new stake in shares of AdaptHealth in the 4th quarter valued at approximately $181,000. 82.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Truist Financial decreased their target price on AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, May 12th. Royal Bank Of Canada decreased their price target on AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a research note on Thursday, May 8th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, AdaptHealth currently has an average rating of "Buy" and a consensus price target of $13.40.

AdaptHealth Stock Performance

Shares of AHCO opened at $9.22 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.29 and a debt-to-equity ratio of 1.25. The business's 50 day moving average price is $8.99 and its 200-day moving average price is $9.40. AdaptHealth Corp. has a 52 week low of $7.11 and a 52 week high of $11.90. The stock has a market cap of $1.24 billion, a P/E ratio of 16.18, a P/E/G ratio of 1.07 and a beta of 1.63.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.